Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese marketing approval for CardioVascular Dynamics:

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health has given CardioVascular Dynamics the go-ahead to market eight new models of the company's Lynx catheters. The devices use CVD's patented technology to treat atherosclerosis by focusing most of the dilatation force during treatment directly to the lesion site. This prevents the balloon dilatation damaging the surrounding arterial wall. The Lynx catheters can also be used in other interventional procedures.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086571

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel